Epacria Capital Partners’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,107
Closed -$628K 37
2025
Q1
$628K Sell
4,107
-36
-0.9% -$5.66K 0.51% 30
2024
Q4
$620K Sell
4,143
-8,948
-68% -$1.4M 0.52% 33
2024
Q3
$2.15M Hold
13,091
1.46% 20
2024
Q2
$1.81M Hold
13,091
1.33% 21
2024
Q1
$1.81M Hold
13,091
1.31% 22
2023
Q4
$1.37M Hold
13,091
1.1% 26
2023
Q3
$1.24M Hold
13,091
1.02% 25
2023
Q2
$1.32M Sell
13,091
-2,684
-17% -$249K 1.08% 25
2023
Q1
$1.28M Hold
15,775
0.99% 28
2022
Q4
$1.18M Buy
+15,775
New +$1.23M 0.93% 30

Other funds holding DVA

Epacria Capital Partners's DVA Position: Q2 2025 in Review

Epacria Capital Partners sold out of DaVita (DVA) in Q2 2025, closing a stake of 4,107 shares — an estimated $628K sold.

Epacria Capital Partners first reported a position in DVA in Q4 2022 and held it in 10 quarters. The position peaked at $2.15M in Q3 2024. 593 funds tracked by Wall St. Rank hold DVA as of Q2 2025.

  • Epacria Capital Partners reported no remaining DaVita position as of Q2 2025 after selling out during the quarter.
  • Epacria Capital Partners sold 4,107 DaVita shares in Q2 2025, an estimated $628K.
  • Epacria Capital Partners first reported a position in DaVita in Q4 2022 and held it in 10 quarters.
  • Epacria Capital Partners's DaVita position peaked at $2.15M in Q3 2024.
  • 593 funds tracked by Wall St. Rank held DaVita as of Q2 2025.

Based on Epacria Capital Partners's 13F filing for Q2 2025, filed 13 Aug 2025.